Correction to: A prospective randomized trial comparing corifollitropin-α late-start (day 4) versus standard administration (day 2) in expected poor, normal, and high responders undergoing controlled ovarian stimulation for IVF

Eitemau Tebyg

• A prospective randomized trial comparing corifollitropin-α late-start (day 4) versus standard administration (day 2) in expected poor, normal, and high responders undergoing controlled ovarian stimulation for IVF
  gan: Revelli, Alberto, et al.
  Cyhoeddwyd: (2020)
• Correction to: A prospective randomized trial comparing corifollitropin-α late-start (day 4) versus standard administration (day 2) in expected poor, normal, and high responders undergoing controlled ovarian stimulation for IVF
  gan: Revelli, Alberto, et al.
  Cyhoeddwyd: (2021)
• Efficacy and safety of late-start Corifollitropin-alfa administration for controlled ovarian hyperstimulation in IVF: a cohort, case–control study
  gan: Revelli, Alberto, et al.
  Cyhoeddwyd: (2015)
• Luteal Support with very Low Daily Dose of Human Chorionic Gonadotropin after Fresh Embryo Transfer as an Alternative to Cycle Segmentation for High Responders Patients Undergoing Gonadotropin-Releasing Hormone Agonist-Triggered IVF
  gan: Carosso, Andrea Roberto, et al.
  Cyhoeddwyd: (2021)
• Impact of the addition of Early Embryo Viability Assessment to morphological evaluation on the accuracy of embryo selection on day 3 or day 5: a retrospective analysis
  gan: Revelli, Alberto, et al.
  Cyhoeddwyd: (2019)